These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 5897862

  • 21. [Chemotherapy of lung tuberculosis].
    Iatsozhinskiĭ IuD, Kulik NM, Molotkov VN.
    Vrach Delo; 1977 Apr; (4):68-70. PubMed ID: 860508
    [No Abstract] [Full Text] [Related]

  • 22. Combined therapy with isoniazid and ethionamide in ulcero-caseous tuberculosis.
    Cornea P, Nisim F, Nicoulescu F.
    Ther Hung; 1966 Apr; 14(1):24-9. PubMed ID: 5946507
    [No Abstract] [Full Text] [Related]

  • 23. A pilot trial of rifampicin in tuberculosis.
    Baronti A, Lukinovich N.
    Tubercle; 1968 Jun; 49(2):180-6. PubMed ID: 5664316
    [No Abstract] [Full Text] [Related]

  • 24. Results of treatment of patients with pulmonary tuberculous with a combination of cycloserine and other tuberculostatics.
    Raboukhine A.
    Scand J Respir Dis Suppl; 1970 Jun; 71():155-8. PubMed ID: 5271977
    [No Abstract] [Full Text] [Related]

  • 25. [Pulmonary tuberculosis with early verification].
    Anzalone M, Franco M, Rangoni R, Rossi F, Simonetti M.
    G Pneumol; 1970 Dec; 14(4):209-27. PubMed ID: 5526259
    [No Abstract] [Full Text] [Related]

  • 26. Drug sensitivity in pulmonary tuberculosis. Incidence of primary and acquired drug-resistance in 1960-1963.
    Selroos O, Brander L.
    Acta Tuberc Pneumol Scand; 1965 Dec; 46(3):197-206. PubMed ID: 5880140
    [No Abstract] [Full Text] [Related]

  • 27. [Clinical significance of the resistance to the classical tuberculostatics].
    Eule H.
    Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):319-24. PubMed ID: 5897859
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Basic and clinical study of 2-propyl isonicotinic thioamide (1321 Th)].
    Hokama S, Naruto H, Sugiura H, Matsumiya T, Fukuhara Y.
    Saishin Igaku; 1967 Sep 10; 22(9):2073-80. PubMed ID: 6082217
    [No Abstract] [Full Text] [Related]

  • 30. [Levels of isonicotinic acid amide in patients with pulmonary tuberculosis treated with isonicotinic acid hydrazide and ethionamide].
    Sosnowski W, Rozniecki J, Podoska M, Galamon T.
    Gruzlica; 1970 Oct 10; 38(11):1089-95. PubMed ID: 4249764
    [No Abstract] [Full Text] [Related]

  • 31. [Clinical problems of resistance to secondary antitubercular agents].
    Baba H, Takahashi R, Nakai T, Torii R, Yo I.
    Iryo; 1966 Mar 10; 20(3):230-40. PubMed ID: 5964830
    [No Abstract] [Full Text] [Related]

  • 32. [Simultaneous determination of INH and ethionamide concentration in the lung].
    Eule H, Werner E.
    Z Tuberk Erkr Thoraxorg; 1965 Jul 10; 123(4):335-8. PubMed ID: 5897863
    [No Abstract] [Full Text] [Related]

  • 33. Ethionamide, 750 mg. daily, plus isoniazid, 450 mg. daily, in previously untreated cases of pulmonary tuberculosis.
    Lees AW.
    Am Rev Respir Dis; 1965 Dec 10; 92(6):966-9. PubMed ID: 5844257
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Practical results of standard first-line treatment in pulmonary tuberculosis : influence of primary resistance.
    Abderrahim K, Chaulet P, Oussedik N, Amrane R, Hassen CS, Mercer N.
    Bull Int Union Tuberc; 1976 Dec 10; 51(1):359-66. PubMed ID: 1030307
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Pluriresistant tuberculous bacilli in developing countries: value of sensitivity tests with antibiotic combinations].
    Chataigneau P, Castets M.
    Rev Tuberc Pneumol (Paris); 1970 Dec 10; 34(3):454-6. PubMed ID: 5510438
    [No Abstract] [Full Text] [Related]

  • 38. [Therapeutic results in lung diseases caused by atypical mycobacteria].
    Fischer P, Schilling W.
    Z Erkr Atmungsorgane; 1984 Dec 10; 162(1):26-9. PubMed ID: 6202070
    [Abstract] [Full Text] [Related]

  • 39. Susceptibility tests to second line drugs and re-treatment of tuberculosis revisiting early experiences.
    de Kantor IN, Barrera L.
    Medicina (B Aires); 2007 Dec 10; 67(3):231-7. PubMed ID: 17628909
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.